From Startup Aduro Biotech Link to Full Article: BERKELEY, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the following upcoming investor conferences: Cantor Fitzgerald 2018 Global Healthcare Conference in
From Startup Neon Therapeutics Link to Full Article: CAMBRIDGE, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) — Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that Hugh O’Dowd, President and Chief Executive Officer of Neon, will present at the following upcoming investor conferences: Ladenburg Thalmann 2018
From Startup Sophiris Bio Link to Full Article: http://investor.sophirisbio.com/news-releases/news-release-details/sophiris-bio-present-cantor-global-healthcare-conference SAN DIEGO and VANCOUVER, British Columbia, Sept. 25, 2018 /PRNewswire/ — Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today announced
From Startup Urovant Link to Full Article: https://urovant.com/2018/09/25/kyorin-receives-approval-from-japans-ministry-of-health-labour-and-welfare-for-vibegron-for-overactive-bladder/ Kyorin secures first commercial approval for vibegron Vibegron will be a new treatment option in Japan, where an estimated 10.4 million people suffer from overactive bladder symptoms defined as the sudden urge to urinate, frequent urination and urge incontinence BASEL, Switzerland and IRVINE, Calif., Sept.
From Startup Eidos Therapeutics Link to Full Article: http://ir.eidostx.com/news-releases/news-release-details/eidos-therapeutics-present-leerink-partners-roundtable-series SAN FRANCISCO, Sept. 25, 2018 (GLOBE NEWSWIRE) — Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will participate in a fireside chat at the Leerink Partners Roundtable Series: Rare Disease & Oncology on Tuesday, October 2, 2018 at 3:30 p.m.
From Startup Synlogic Tx Link to Full Article: CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sep. 25, 2018– Synlogic(Nasdaq:SYBX) announced today that Aoife Brennan, M.B., B.Ch., Synlogic’s interim president and chief executive officer, and chief medical officer, will present a corporate update at the Leerink Partners Roundtable Series on Rare Diseases and Oncology at 11:30
From Startup CareTeam Link to Full Article: Who made the final cut? Just 10 companies are still in the running for top prizes in this year’s Innovate BC-New Ventures Competition. Want to see who wins? You can only find out at the Awards. 2018 Innovate BC-New Ventures Competition Top 10
From Startup crosschx Link to Full Article: It’s Your Job To Figure That Out When you’re building a product for someone, the first thing you need to know is that your customer probably doesn’t care. They will care. Once you’ve finished the product, put it in their hands, and made